05/23/2026
Despite tremendous investments over many decades, 99% of drug candidates for Alzheimer's disease fail to show any benefit in clinical trials.
Now, researchers at WashU Medicine plan to use a grant from the National Science Foundation and Microsoft to build an "AI Scientist" system to increase the efficiency and effectiveness of Alzheimerβs disease research.
Research WashU Medicine researchers to build AI tools to boost Alzheimerβs research By Katie Cammarata β’ April 15, 2026April 15, 2026 Credit: Getty Images WashU Medicine has been awarded nearly $800,000 by the National Artificial Intelligence Research Resource (NAIRR) Pilot program, an initiativ...